In a murine model of T‐cell activation, Acthar reduced the activation of CD4+ and CD8+ T cells as well as the production of cytokines (interleukin‐2, interferon γ, and TNFα), which are involved in inflammatory immune responses in autoimmune disorders, such as multiple sclerosis (Wright & Hayes, 2023). Here, CD4 is linked to multiple sclerosis.